Diminished prostaglandin E2 contributes to the apoptosis paradox in idiopathic pulmonary fibrosis
about
Reciprocal regulation of TGF-β and reactive oxygen species: A perverse cycle for fibrosisFibroblasts in fibrosis: novel roles and mediatorsMyofibroblasts and lung fibrosis induced by carbon nanotube exposure17β-Estradiol alters rat type-II alveolar cell recovery from high levels of ozone.Mononuclear phagocytes and airway epithelial cells: novel sources of matrix metalloproteinase-8 (MMP-8) in patients with idiopathic pulmonary fibrosis.Matrix metalloproteinase-19 is a key regulator of lung fibrosis in mice and humansRole of the lysophospholipid mediators lysophosphatidic acid and sphingosine 1-phosphate in lung fibrosis.Prostaglandin E2 inhibits α-smooth muscle actin transcription during myofibroblast differentiation via distinct mechanisms of modulation of serum response factor and myocardin-related transcription factor-AProteases Revisited: Roles and Therapeutic Implications in Fibrosis.Targeting interleukin-13 with tralokinumab attenuates lung fibrosis and epithelial damage in a humanized SCID idiopathic pulmonary fibrosis model.Pathogenesis of idiopathic pulmonary fibrosisLung fibroblasts from patients with idiopathic pulmonary fibrosis exhibit genome-wide differences in DNA methylation compared to fibroblasts from nonfibrotic lungHydrogel scaffolds as in vitro models to study fibroblast activation in wound healing and disease.Lack of microsomal prostaglandin E synthase-1 reduces cardiac function following angiotensin II infusionLung myofibroblasts are characterized by down-regulated cyclooxygenase-2 and its main metabolite, prostaglandin E2.Novel therapeutic approaches for pulmonary fibrosis.Prostaglandin E2 and the pathogenesis of pulmonary fibrosis.Inhibition of myocardin-related transcription factor/serum response factor signaling decreases lung fibrosis and promotes mesenchymal cell apoptosis.Prostaglandin Transporter (PGT/SLCO2A1) Protects the Lung from Bleomycin-Induced Fibrosis.Survivin expression induced by endothelin-1 promotes myofibroblast resistance to apoptosis.Prostaglandin E2 as an inhibitory modulator of fibrogenesis in human lung allograftsPlakoglobin expression in fibroblasts and its role in idiopathic pulmonary fibrosis.Characterization of Lung Fibroblasts More than Two Decades after Mustard Gas ExposureThe lysophosphatidic acid receptor LPA1 promotes epithelial cell apoptosis after lung injuryCaveolin-1 deficiency protects from pulmonary fibrosis by modulating epithelial cell senescence in mice.Invasive breast cancer induces laminin-332 upregulation and integrin β4 neoexpression in myofibroblasts to confer an anoikis-resistant phenotype during tissue remodeling.Genetic partitioning of interleukin-6 signalling in mice dissociates Stat3 from Smad3-mediated lung fibrosis.Epigenetic regulation of cyclooxygenase-2 by methylation of c8orf4 in pulmonary fibrosisTargeting Inhibitor of Apoptosis Proteins Protects from Bleomycin-Induced Lung Fibrosis.Matrices of physiologic stiffness potently inactivate idiopathic pulmonary fibrosis fibroblasts.Histone modifications are responsible for decreased Fas expression and apoptosis resistance in fibrotic lung fibroblasts.Computational Modeling Predicts Simultaneous Targeting of Fibroblasts and Epithelial Cells Is Necessary for Treatment of Pulmonary Fibrosis.X-linked inhibitor of apoptosis regulates lung fibroblast resistance to Fas-mediated apoptosis.Heparin and LPS-induced COX-2 expression in airway cells: a link between its anti-inflammatory effects and GAG sulfation.Skewed Lung CCR4 to CCR6 CD4+ T Cell Ratio in Idiopathic Pulmonary Fibrosis Is Associated with Pulmonary Function.Mouse Lung Fibroblast Resistance to Fas-Mediated Apoptosis Is Dependent on the Baculoviral Inhibitor of Apoptosis Protein 4 and the Cellular FLICE-Inhibitory Protein.Update in diffuse parenchymal lung disease 2010.Myofibroblast differentiation and survival in fibrotic disease.Targeting defective Toll-like receptor-3 function and idiopathic pulmonary fibrosis.Regulation and Relevance of Myofibroblast Responses in Idiopathic Pulmonary Fibrosis.
P2860
Q26779846-85F849FC-8D00-4216-BEF5-77A5F241F248Q26998508-419D7F8F-0113-4DF1-ACFC-8A12317D547CQ27969008-1A9F5CC3-F77E-4804-B1CC-EA2BB338FCE8Q31152613-094FA2E9-2879-4375-B526-1B1494085631Q33610227-C8103105-E856-4AAF-ADF5-3FDD12025650Q33745690-75CD9268-5060-408E-BFFE-D29A8A61B768Q33756825-C7EB9001-0EFE-4E3B-83C5-E43FC6865557Q33761334-A2F8D9AB-0665-4FDC-BE14-2D900D784E33Q33795055-F402ECD4-23DC-452B-A33E-8B7E5133D055Q33799732-F561D12C-C8ED-47F4-88E1-930C6737D871Q33976506-03B5F844-87CC-4D72-AA52-E9041CBFDE3FQ34172455-565F7B7D-F8F1-4B7B-B535-3DB50EA89464Q34441135-3ED8319A-437C-49A2-A4D4-B96F27F84C62Q34720276-3DC5D557-D968-4CD7-9D28-EF0BAA378AE3Q34766530-9188AAEB-7199-4EAC-856C-2CF4621863ECQ34903224-BC9E6E67-9BB7-48B4-8F4A-9C44CFE1CB91Q35219865-7D1CE857-918F-4B20-9405-B294DA719E73Q35236478-2025634F-DB63-41FA-828C-86D417EEF236Q35617407-A3715D6F-BD7A-41EB-AA81-D4DCB0537247Q35621434-5B4533A4-88DA-43E4-BCD8-696D2A1E665AQ35683015-CE687078-BD3E-4B8D-8BB8-8C71EC04227CQ35834753-2DF8B049-62C3-4407-B6CB-BE34F27B815DQ35872285-26BC598A-6BE2-45A8-B0DC-B585839D1836Q35889195-93117432-01D5-42BA-A54D-240B8C6ACFF5Q36110540-66B321CB-0DC3-4BB4-AAA8-775F981C43DCQ36245413-EFF8E37D-98A6-4BA9-A5C0-2491DE0F98FCQ36379511-0B892252-F192-4C8F-B652-DAC077D452BAQ36661876-6C3AA501-1291-4024-8A3F-68A247CE2CB9Q36765978-640496CE-424E-47E2-BBB8-FE24034162D9Q36842944-903EAD30-5D51-49A6-919C-D6623FB68F57Q36907090-A36A6399-3DBF-4BE9-BD55-01A68D896601Q37030035-0360A6C2-C6C4-4060-9AB7-A5C6C0AC936DQ37056479-745162E1-8A86-4DC8-8B17-548DF894562FQ37129696-E321AE4E-9D2E-483F-9E48-9DF1D493C710Q37430348-851EA71D-759F-4A50-AC19-54EADE8E4CC7Q37697394-7F2CA64C-D9ED-461D-86D8-DF7075CF4BCEQ37877430-E18174DF-1C34-4E5F-BD98-8B7958D1253EQ37921386-812C0986-E043-4F0D-9F24-9BCD62542F7FQ38296340-EEE1C060-EAC1-48BE-B43B-45F210B00E03Q38364228-6C7A2E1C-817C-4218-BB4C-730BFAA49091
P2860
Diminished prostaglandin E2 contributes to the apoptosis paradox in idiopathic pulmonary fibrosis
description
2010 nî lūn-bûn
@nan
2010 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մարտին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Diminished prostaglandin E2 co ...... idiopathic pulmonary fibrosis
@ast
Diminished prostaglandin E2 co ...... idiopathic pulmonary fibrosis
@en
type
label
Diminished prostaglandin E2 co ...... idiopathic pulmonary fibrosis
@ast
Diminished prostaglandin E2 co ...... idiopathic pulmonary fibrosis
@en
prefLabel
Diminished prostaglandin E2 co ...... idiopathic pulmonary fibrosis
@ast
Diminished prostaglandin E2 co ...... idiopathic pulmonary fibrosis
@en
P2093
P2860
P1476
Diminished prostaglandin E2 co ...... idiopathic pulmonary fibrosis
@en
P2093
Andrew G Nicholson
Andrew J Thorley
Geoffrey J Laurent
Iona C Evans
Paul F Mercer
Rachel C Chambers
Robin J McAnulty
Stephen E Bottoms
Teresa D Tetley
Toby M Maher
P2860
P356
10.1164/RCCM.200905-0674OC
P407
P577
2010-03-04T00:00:00Z